Reduction of oxidative stress by carvedilol: Role in maintenance of ischaemic myocardium viability

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 556-566

  Cargnoni, Anna ^a   Ceconi, Claudio ^b   Bernocchi, Palmira ^a   Boraso, Antonella ^a   Parrinello, Giovanni ^b   Curello, Salvatore ^b   Ferrari, Roberto ^c  

^a IRCCS   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Adrenergic (ant)agonists; Free radicals; Ischemia; Ventricular function

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATINE KINASE; GLUTATHIONE; PROPRANOLOL; THIOL GROUP;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FUNCTION; INOTROPISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; PERFUSION; PHOSPHOCREATINE; PROPANOLAMINES; PROPRANOLOL; RABBITS; RANDOM ALLOCATION;

EID: 0034683047     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00082-1     Document Type: Article

References (32)

1. Indications for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100 000 patients in randomized trials. Circulation. 97:1998;2202-2212.
2. Garg R., Yusuf S. For the collaborative group on ACE inhibitors on mortality and morbidity in patients with heart failure. J Am Med Assoc. 273:1995;1450-1456.
3. Feuerstein G.Z., Ruffolo R.R. Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J. 16:(suppl F):1995;38-42.
4. Yue T.-L., Cheng H.-Y., Lysko P.G., et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 263:1992;92-98.
5. Yue T.-L., Mckenna P.J., Ruffolo R.R. Jr., Feuerstein G. Carvedilol, a new beta adrenergic antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol. 214:1992;277-280.
6. Feuerstein G.Z., Hamburger S.A., Smith E.F., Bril A., Ruffolo R.R. Jr. Myocardial protection with carvedilol. J Cardiovasc Pharmacol. 19:1992;S138-S141.
7. Hamburger S.A., Barone F.C., Feuerstein G.Z., Ruffolo R.R. Jr. Carvedilol (kredex) reduces infarct size in canine model of acute myocardial infarction. Pharmacology. 43:1991;113-120.
8. Bril A., Slivjak M.J., Dimartino M.J., et al. Cardioprotective effects of carvedilol, a novel beta-adrenoceptor antagonist with vasodilating properties, anaesthetised minipigs: comparison with propranolol. Cardiovasc Res. 26:1992;518-525.
9. Feuerstein G.Z., Yue T.-L., Cheng H.-Y., Ruffolo R.R. Jr. Myocardial protection by the novel vasodilating beta-blocker carvedilol: potential relevance of antioxidant activity. J Hypertens. 11:(suppl 4):1993;S41-S48.
10. Ma X.L., Yue T.L., Lopez B.L., et al. Carvedilol, a new beta adrenoceptor blocker and free radical scavenger, attenuates myocardial ischaemia-reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther. 277:1996;128-136.
11. Brunvand H., Kvitting P.M., Rynning S.E., Berge R.K., Grong K. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms. J Cardiovasc Pharmacol. 28:1996;409-417.
12. Brunvand H., Froyland L., Hexeberg E., Rynning S.E., Berge R.K., Grong K. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. Eur J Pharmacol. 314:1996;99-107.
13. Feuerstein G.Z., Bril A., Ruffolo R.R. Jr. Protective effect of carvedilol in the myocardium. Am J Cardiol. 80:(11A):1997;41L-45L.
14. Yue T.-L., Liu T., Feuerstein G. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, inhibits oxygen radical mediated lipid peroxidation in swine ventricular membranes. Pharmacol Commun. 1:1992;27-35.
15. Aruoma O.I., Smith C., Cecchini R., Evans P.J., Haaliwell B. Free radical scavenging and inhibition of lipid peroxidation by β-blockers and by agents that interfere with calcium metabolism. Biochem Pharmacol. 42:1991;735-743.
16. Ceconi C., Curello S., Cargnoni A., Ferrari R., Albertini A., Visioli O. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects on N-acetyl cysteine. J Mol Cell Cardiol. 20:1988;5-13.
17. Oliver T.A. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 61:1955;116-122.
18. Tietze F. Enzymatic method for quantitative of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissue. Anal Biochem. 27:1969;502-522.
19. Bernocchi P., Ceconi C., Cargnoni A., Pedersini P., Curello S., Ferrari R. Extraction and assay of creatine phosphate, purine and pyridine in cardiac tissue by reversed-phase high-performance liquid chromatography. Anal Biochem. 222:1994;374-379.
20. Sedlack J., Lindsay R.H. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Elmann's reagent. Anal Biochem. 25:1968;192-205.
21. Bradford M.M. Rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein binding. Anal Biochem. 72:1978;248-254.
22. Bush L R., Haack D W., Shlafer M., Lucchesi B R. Protective effects of β-adrenergic blockade in isolated ischaemic hearts. Eur J Pharmacol. 67:1980;209-217.
23. Kübler W., Spieckermann P G. Regulation of glycolysis in the ischaemic and anoxic myocardium. J Mol Cell Cardiol. 1:1970;351-355.
24. Geisbuhler T., Altschuld R.A., Trewyn R.W., Ansel A.Z., Lamka K., Brierley G.P. Adenine nucleotide metabolism and compartimentalization in isolated adult rat heart cells. Circ Res. 54:1984;536-546.
25. Esumi K., Nishida M., Shaw D., Smith T.W., Marsh J.D. NADH measurements in adult rat myocytes during simulated ischaemia. Am J Physiol. 260:1991;H1743-1752.
26. Garlick P B., Davies M J., Hearse D J., Slater T F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res. 5:1987;757-760.
27. Zweier J L. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem. 263:1988;1353-1357.
28. Ferrari R., Ceconi C., Curello S., et al. Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol. 17:1985;937-945.
29. Simpson P J., Lucchesi B R. Free radicals and myocardial ischaemia and reperfusion injury. J Lab Clin Med. 110:1987;13-30.
30. Curello S., Ceconi C., Bigoli C., Ferrari R., Albertini A., Guarnieri C. Changes in the cardiac glutathione status after ischaemia and reperfusion. Experientia. 41:1985;42-43.
31. Ferrari R., Alfieri O., Curello S., et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation. 81:1990;201-211.
32. Cargnoni A., Ceconi C., Bernocchi P., et al. Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies. J Heart Lung Transplant. 18:1999;478-487.